Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Dupilumab> ?p ?o }
Showing triples 1 to 60 of
60
with 100 triples per page.
- Dupilumab abstract "Dupilumab is a monoclonal antibody designed for the treatment of atopic diseases. It binds to the alpha subunit of the interleukin-4 receptor (IL-4Rα). Through blockade of IL-4Rα, dupilumab modulates signaling of both the interleukin 4 and interleukin 13 pathway, which have been implicated in the pathophysiology of allergic disease, particularly asthma and atopic dermatitis.This drug was developed by Regeneron Pharmaceuticals.In 2013 mid-stage data was presented at the American Thoracic Society meeting and published in the NEJM demonstrating an 87% (placebo: 67%) reduction in asthma exacerbations in patients with moderate-to-severe allergic asthma. In an atopic dermatitis study, 85% of patients improved their symptoms by at least 50% within twelve weeks (measured by eczema area and severity index), versus 35% in the placebo group.".
- Dupilumab atcPrefix "none".
- Dupilumab casNumber "1190264-60-8".
- Dupilumab wikiPageID "36964617".
- Dupilumab wikiPageLength "2912".
- Dupilumab wikiPageOutDegree "12".
- Dupilumab wikiPageRevisionID "660234398".
- Dupilumab wikiPageWikiLink Asthma.
- Dupilumab wikiPageWikiLink Atopic.
- Dupilumab wikiPageWikiLink Atopic_dermatitis.
- Dupilumab wikiPageWikiLink Atopy.
- Dupilumab wikiPageWikiLink Category:Monoclonal_antibodies.
- Dupilumab wikiPageWikiLink Eczema_Area_and_Severity_Index.
- Dupilumab wikiPageWikiLink Eczema_area_and_severity_index.
- Dupilumab wikiPageWikiLink Interleukin-4_receptor.
- Dupilumab wikiPageWikiLink Interleukin_13.
- Dupilumab wikiPageWikiLink Interleukin_4.
- Dupilumab wikiPageWikiLink NEJM.
- Dupilumab wikiPageWikiLink Placebo.
- Dupilumab wikiPageWikiLink Regeneron.
- Dupilumab wikiPageWikiLink The_New_England_Journal_of_Medicine.
- Dupilumab wikiPageWikiLinkText "Dupilumab".
- Dupilumab atcPrefix "none".
- Dupilumab c "6512".
- Dupilumab casNumber "1190264".
- Dupilumab chemspiderid "NA".
- Dupilumab h "10066".
- Dupilumab hasPhotoCollection Dupilumab.
- Dupilumab mabType "mab".
- Dupilumab molecularWeight "146.9".
- Dupilumab n "1730".
- Dupilumab o "2052".
- Dupilumab s "46".
- Dupilumab source "u".
- Dupilumab target "IL4 receptor alpha".
- Dupilumab type "mab".
- Dupilumab wikiPageUsesTemplate Template:Drugbox.
- Dupilumab wikiPageUsesTemplate Template:Monoclonal-antibody-stub.
- Dupilumab wikiPageUsesTemplate Template:Monoclonals_for_immune_system.
- Dupilumab subject Category:Monoclonal_antibodies.
- Dupilumab hypernym Antibody.
- Dupilumab type Article.
- Dupilumab type ChemicalSubstance.
- Dupilumab type Drug.
- Dupilumab type Antibody.
- Dupilumab type Article.
- Dupilumab type Chemical.
- Dupilumab type Drug.
- Dupilumab type ChemicalObject.
- Dupilumab type Thing.
- Dupilumab type Q8386.
- Dupilumab comment "Dupilumab is a monoclonal antibody designed for the treatment of atopic diseases. It binds to the alpha subunit of the interleukin-4 receptor (IL-4Rα).".
- Dupilumab label "Dupilumab".
- Dupilumab sameAs دوبيلوماب.
- Dupilumab sameAs Dupilumab.
- Dupilumab sameAs m.0m0hpyd.
- Dupilumab sameAs Q5315925.
- Dupilumab sameAs Q5315925.
- Dupilumab wasDerivedFrom Dupilumab?oldid=660234398.
- Dupilumab isPrimaryTopicOf Dupilumab.